Patents by Inventor Weimei Xing

Weimei Xing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutant reverse transcriptase and methods of use
    Patent number: 9783791
    Abstract: The invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The invention also discloses methods of using stable MMLV reverse transcriptase mutants.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: October 10, 2017
    Assignee: Agilent Technologies, Inc.
    Inventors: Holly Hogrefe, Bahram Arezi, Weimei Xing
  • Mutant Reverse Transcriptase and Methods of Use
    Publication number: 20160340657
    Abstract: The invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The invention also discloses methods of using stable MMLV reverse transcriptase mutants.
    Type: Application
    Filed: April 4, 2016
    Publication date: November 24, 2016
    Applicant: Agilent Technologies, Inc.
    Inventors: Holly H. Hogrefe, Bahram Arezi, Weimei Xing
  • Mutant reverse transcriptase and methods of use
    Publication number: 20080227661
    Abstract: The invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The invention also discloses methods of using stable MMLV reverse transcriptase mutants.
    Type: Application
    Filed: August 10, 2006
    Publication date: September 18, 2008
    Inventors: Holly Hogrefe, Bahram Arezi, Weimei Xing